Weiran Liu
Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Doxorubicin compromises blood-brain barrier integrity by suppressing annexin A1 expression.
Journal: Open life sciences
Published: September 22, 2025
Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial.
Journal: Signal transduction and targeted therapy
Published: July 25, 2025
ASO Author Reflections: The Candidate Biomarkers for Predicting Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
Journal: Annals of surgical oncology
Published: August 20, 2024
Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma.
Journal: Translational lung cancer research
Published: June 13, 2024
Comprehensive Analysis of Immune Responses to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer.
Journal: Annals of surgical oncology
Published: January 04, 2024
Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: October 18, 2022
A novel approach for the non-invasive diagnosis of pulmonary nodules using low-depth whole-genome sequencing of cell-free DNA.
Journal: Translational lung cancer research
Published: June 29, 2022
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients.
Journal: Translational lung cancer research
Published: November 23, 2021
Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 19, 2018
TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.
Journal: Journal of cancer research and clinical oncology
Published: November 14, 2018
B3GNT3 overexpression is associated with unfavourable survival in non-small cell lung cancer.
Journal: Journal of clinical pathology
Published: October 20, 2017
Last Updated: 09/26/2026